Intuitive Surgical | ISRG - Ebitda


Intuitive Surgical reported $1.06B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Agilent USD 456M 84M Dec/2025
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.63B 27M Jun/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
CONMED USD 78.12M 21.73M Jun/2026
Danaher USD 1.84B 81M Jun/2026
Dentsply International USD 129M 6M Mar/2026
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Globus Medical USD 231.83M 48.62M Mar/2026
Illumina USD 330M 80M Jun/2026
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 78.41M 2.23M Jun/2026
Intuitive Surgical USD 1.06B 29.9M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Mettler Toledo International USD 322.64M 43.66M Jun/2026
Olympus JPY 43.41B 2.31B Mar/2026
Revvity USD 228.18M 44.73M Jun/2026
Steris USD 443M 48.3M Mar/2026
Stryker USD 1.93B 357M Jun/2026
Teleflex USD 75.63M 171.44M Mar/2026
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Waters USD 712M 545M Jun/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026